Market Research Logo

Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Edition

The information represented in this report is a comprehensive analysis of the eye care market globally with a special focus on the United States and selected international sectors. The year ending December 31, 2008 was used as the base year with forecasts to the year 2013. Market statistics are given in U.S. dollars and in units [where appropriate]. Basis for the market analysis consists of key data, statistics; references, and information from a large data base of primary and secondary research sources documented in the report consisting of interviews, professional meetings; conferences; presentations; journals; consumer media [radio, TV, magazines, newspapers]; and Internet content involving more than 40,000 sources. Data were collected for global populations and medical providers who represent the key influences in the eye care market.

The market analysis is comprised of two major sectors:

  • refractive vision correction [addressing myopia, hyperopia, presbyopia, and astigmatism]
  • and major eye diseases [addressing cataracts, glaucoma, AMD, retinal disorders].
Within the primary sectors the analysis includes the top RVC treatment modalities [traditional and advanced laser systems; RVC lens implants, and alternative surgical implants] and surgical intervention for each of the major diseases [retinal laser surgery, photo dynamic therapy, pneumatic thermoplasticy, capsulectomy, and trabeculectomy]. Competitive market shares are given for the key manufacturers of RVC treatment methodologies and for major devices and ophthalmic therapeutics employed in the management of eye diseases.

New technologies and treatment modalities for both visual acuity and major eye diseases may dramatically change the composition and competitive dynamics of the ophthalmology market. This report explores these dynamics and discoveries along with their profound impact on clinical eye care and the competitive positions of the market supplier. Also examined are traditional [conventional] approaches, the role of medical skills and techniques developed and cultivated over past years, and the importance of supporting increasingly global demand to correct vision deficiencies.

Other competitive technologies presented herein under the heading of refractive vision correction [RVC] include:

  • Integrated [diagnostic] laser surgery
  • RF conductive keratoplasty
  • Earlier versions of corrective laser systems.
This segment also includes RVC breakthrough technologies such as
  • Imaging topography
  • Accommodating implants
  • Special vision lens
  • Vision restoration systems and
  • Other evolving technologies
Vision abnormalities [restoration of impaired vision] presented and investigated are confined to following four primary conditions:
  • Myopia [nearsightedness]—leading eye disorder affecting all age groups
  • Hyperopia [farsightedness]—second leading eye disorder affecting all age groups
  • Presbyopia [near focus abnormality]—phenomenon of aging, mostly 40 + year olds
  • Astigmatism [cornea irregularities, eye globe distortion]—affects all age groups
The range of therapeutic modalities mentioned above offers multiple options in treating one or more of the four primary diseases. While some modalities like ophthalmic pharmaceuticals are used to treat one disease, other medical devices like lasers and implants [Refocus Group’s PresView SRP—Scleral Lens Spacers] are more flexible and used in multiple applications for disease-specific procedures.

The market described herein is also positioning itself to resolve its most compelling problems effecting older populations—the alarming increase in loss of vision worldwide resulting from diseases, aging, and declining health conditions. The race is underway to develop and exploit cutting-edge technologies [diagnostics, imaging, therapeutics, devices] that will address the growing threat of deteriorating vision and blindness caused by the most serious eye diseases, including:

  • Cataracts—surgery & replacement intra ocular lens [IOL] and accommodating lens,
  • Glaucoma/Ocular Hypertension—chronic opened-angle and acute closedangle • Age-Related Macular Degeneration [AMD]—both wet and dry, and
  • Retinal Disorders—diabetic retinopathy, diabetic edema, detached retina.
While technological innovations continue to play a crucial role in slowing [or stopping] the progress of vision loss through laser surgery and other medical and therapeutic intervention, early diagnosis of these diseases and knowledge of available treatment options is equally crucial to prevent the progression and further deterioration of vision. However, the availability of technologies, medical disciplines, and skills to take advantage of the gains made in managing eye diseases has yet to realize its full competitive and market potential. And many players entering this field will find this report a useful resource.


  • Executive Summary
    • OVERVIEW
    • OBJECTIVES, SCOPE, AND METHODOLOGY
    • SUMMARY OF FINDINGS
      • Overview of Current Market Dynamics
        • Table Ophthalmology Market: Product and Service Revenues [combined eye diseases and refractive], 2006-2013
  • Introduction and Overview
    • OVERVIEW
    • HISTORY IN TREATING EYE DISEASES
    • WORLD DEMOGRAPHICS
      • Table Estimated and Projected World Population by Selected Geographical Region, 2008-2050 (in millions)
      • Table Number and Percent Population by Sex and Region, 2008
      • Table Estimated World Population by Age and Geographical Region, 2008 (in millions)
    • STAGGERING WORLD FACTS
  • Issues and Trends in the Ophthalmology Industry
    • OVERVIEW
    • RESISTANCE TO CHANGE
    • THE NEW TECHNOLOGICAL REVOLUTION
      • Competition: Old vs New
    • REFRACTIVE VISION CORRECTION [RVC]
      • Patient Reported Outcomes for Laser in situ Keratomileusis (LASIK) Surgery
      • World Economy and Refractive Surgery
      • Typical Refractive Demographic 2009
    • MAJOR EYE DISEASES
    • REGULATION
      • Government's Role as Overseer
      • Government Mandate: Safety & Effectiveness
      • Developed & Underdeveloped Countries
      • Off-Label Use
      • Ophthalmologists vs Optometrists
      • Business Challenges in a Regulated Environment
  • Restoration of Impaired Vision
    • TREATMENT OF LEADING VISION DISORDERS
      • The Global Opportunity
      • Conventional Eye Glasses and Contact Lens
      • Other Corrective Modalities
    • CHALLENGES & THREATS IN THE GLOBAL MARKETPLACE
      • Table Primary Visual Acuity Conditions and Refractive Vision Correction Treatment Options
  • Diseases Affecting the Eye
    • OVERVIEW
      • Table Diagnostics & Treatment Modalities for the Management of Eye Diseases (1)
    • CATARACTS
    • GLAUCOMA
    • MACULAR DEGENERATION
    • VITREORETINAL DISORDERS
      • Diabetic Retinopathy [DR]
      • Diabetic Macular Edema [DME]
      • Retinal Detachment [RD]
  • Refractive Vision Correction: Products and Technologies
    • OVERVIEW
      • Competing Treatment Technologies
    • COMPETITIVE PRODUCTS, TECHNOLOGY, APPLICATIONS & MARKET STATUS
      • Table Refractive Vision Correction Competitive Products, Technology, Application, Market Status
  • Major Eye Diseases:Products and Technologies
    • OVERVIEW
    • SUMMARY OF COMPETING TECHNOLOGIES
      • Table Major Eye Diseases Competitors, Competitive Products, Technology, Application, and Market Status
    • CATARACT
    • GLAUCOMA
    • AGE-RELATED MACULAR DEGENERATION
    • VITREORETINAL CONDITIONS
  • Market Summary
    • DESCRIPTION OF THE MARKET
      • Eye Care Challenges
      • The Aging Process and Complications of Chronic Conditions
    • TECHNOLOGY OVERCOMES OBSOLETE METHODOLOGIES
      • Older Treatment Modalities
      • Advanced Treatment Modalities
      • Pressures Influencing Structural Changes
    • MARKET INFLUENCES
      • Table Ophthalmology Market: Product and Service Revenues [combined eye diseases and refractive], 2006-2013
  • Refractive Vision Correction Market Analysis & Forecast
    • BACKGROUND
      • Eye Glasses & Contact Lenses
      • Prevention & Wellness
      • Laser Surgery & Other Corrective Alternatives
    • MARKET AND COMPETITIVE ANALYSIS
      • Refractive Vision Correction Markets: Equipment, Supplies, and Devices
        • Table Refractive Vision Correction Market: Equipment and Product Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
        • Table Refractive Vision Correction Market: Equipment and Product Supplier Revenues and Market Share by Geography, 2008
      • Refractive Vision Correction Markets: Services
        • Table Refractive Vision Correction Market: Service Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
        • Table Refractive Vision Correction Market: Service Revenues and Market Share byProvider Type and Geography, 2008
        • Table Refractive Vision Correction Market: Service Revenues andMarket Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Myopia, Hyperopia, Presbyopia, Astigmatism), 2008
  • Major Eye Diseases: Market Analysis & Forecast
    • MARKET CHALLENGES
    • MARKET AND COMPETITIVE ANALYSIS
      • Eye Disease Markets: Equipment, Supplies, and Devices
        • Table Eye Disease Market: Product Revenues and Annual Growth by Geography(U.S. and Non-U.S.), 2006-2013
        • Table Eye Disease Market: Supplier Revenues and Market Share by Geography, 2008
      • Markets by Eye Disease
      • Cataracts-Surgical Intervention and Devices
      • Glaucoma Treatment and Management
      • Vitreoretinal-Conventional & Advanced Treatments
      • Other Treatments-Allergy, Dry Eye, Infection, Inflammation
        • Table Major Eye Disease Market: Supplier Revenues and Market Share by Condition (Cataract, Glaucoma, Vitreoretinal, Others), 2008
      • Eye Disease Markets: Services
        • Table Eye Disease Treatment Market: Service Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
        • Table Eye Disease Treatment Market: Service Revenues and Market Share by Provider Type and Geography, 2008
        • Table Eye Disease Treatment Market: Provider Service Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated(Cataract, Glaucoma, Vitreoretinal, Other), 2008
  • Company Profiles
    • OVERVIEW
    • ABBOTT MEDICAL OPTICS, INC
      • Products/Technology/Intellectual Property
      • Financial Performance and Segment Analysis
    • ALCON, INC
      • Products/Technology/Intellectual Property
      • Focus & Future Strategy
    • ALLERGAN, INC
      • Business Overview
      • Products and Strategy
    • HEIDELBERG ENGINEERING, INC
      • Business Overview
      • Products and Technology
    • NIDEK CO. LTD.
      • Business Overview
      • Products/Technology/Intellectual Property
    • STAAR SURGICAL COMPANY
      • Business Overview
      • Products/Technology/Intellectual Property
      • Strategy
    • NOVARTIS
      • Business Overview
      • Products & Strategy
    • CARL ZEISS MEDITEC AG
      • Products, Strategy and Focus
  • Glossary and Abbreviations
  • Professional/Scientific Sources
  • News/Research Sources
  • U.S. Regulatory Authorities and Statutes
  • International Regulatory Authorities and Statutes
  • Associations, Societies, Foundations for Eye Health

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report